Viking Therapeutics Stock Dips Despite Positive VK2735 Data: What’s Going On?
Shares of Viking Therapeutics Inc (NASDAQ:VKTX) are down about 5% on Monday. The stock is trending as traders digest a fresh update on the company’s VK2735 under-the-skin injection program.
